20 May 2013
Keywords: nicox, no-aspirin, clears, phase, starts, ii, pad
Article | 22 April 2002
Positive Phase I/IIa clinical results for NicOx of France's NCX 4016,a nitric oxide-donating derivative of aspirin in development for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 April 2002
17 May 2013
© 2013 thepharmaletter.com